COMMUNIQUÉS West-GlobeNewswire

Genetic Technologies Limited: Project Shivom Strategic Alliance
06/03/2018
MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”, “ GTG ”) a diversified molecular diagnostics company; provider of BREVAGen plus ®, a first-in [...]
Transactions in relation to share buyback program
06/03/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Nicox : Aperçu des activités en 2018 et résultats financiers 2017 estimés
06/03/2018
Communiqué de presse Nicox : Aperçu des activités en 2018 et résultats financiers 2017 estimés Commercialisation aux Etats-Unis depuis décembre 2017 de VYZULTA TM (solution ophtalmique de latanoprostène bunod), 0,024% [...]
Nicox provides 2018 Outlook and 2017 Estimated Financial Results
06/03/2018
Press Release Nicox provides 2018 Outlook and 2017 Estimated Financial Results VYZULTA TM (latanoprostene bunod ophthalmic solution), 0.024%, marketed by partner Bausch + Lomb in the U.S. since December 2017 ZERVIATE TM [...]
ERYTECH to Host Fourth Quarter and Full Year 2017 Conference Call and Business Update
06/03/2018
ERYTECH to Host Fourth Quarter and Full Year 2017 Conference Call and Business Update Lyon (France), March 6, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company [...]
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana
06/03/2018
First launch in Latin America Basel, Switzerland, March 06, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that partner Grupo Biotoscana S.L. ("GBT") has launched Basilea's hospital antibiotic Zevtera ® ( [...]
Novartis' Xolair® recommended in new global chronic urticaria guideline
06/03/2018
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], is the only therapy recommended by the guideline for patients unresponsive to antihistamines[2] Xolair is [...]
argenx to Present at Cowen & Company 38th Annual Health Care Conference
06/03/2018
March 6, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach
06/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today issued the following statement regarding the previously announced process for members of [...]
Immutep Announces United States Patent Grant for IMP701 Antibody
06/03/2018
SYDNEY, Australia, March 05, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep”, the “Company”) announces the grant of patent no. 9,908,936 entitled “Antibody molecules to LAG-3 and uses [...]
HealthEquity Sets Date to Announce Year-end Results
05/03/2018
DRAPER, Utah, March 05, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to release its fourth quarter and [...]
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
05/03/2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
MPX Bioceutical Corporation to Host Investor Conference Call on March 8, 2018
05/03/2018
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to provide an operational and financial update to investors. The call [...]
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
05/03/2018
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced that, in connection with its previously announced underwritten public offering of American [...]
Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018
05/03/2018
BUENA, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James 39th Annual Institutional Investors [...]
Cerner Announces New Collaboration with Salesforce to Extend Care Beyond the Exam Room
05/03/2018
KANSAS CITY, Mo., March 05, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, today announced a new collaboration with Salesforce, the global leader in customer relationship management (CRM). [...]
Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Casey Logan has joined the Company as vice president, corporate development. Mr. Logan will report to chief operating [...]
Dynavax to Present at the Cowen & Co. Annual Health Care Conference
05/03/2018
BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s Chief Executive Officer, will present at the Cowen & Co. 38 th Annual [...]
G1 Therapeutics Announces Proposed Offering of Common Stock
05/03/2018
RESEARCH TRIANGLE PARK, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that it has commenced an underwritten public offering of 3,000, [...]

Pages